Back
Protagonist Therapeutics Stock Predictions
Sponsored
PTGX
Sponsored
Biden's Oil War: The Administration Is All-In on Green Energy.
Download Free Report
Sell
48
PTGX
Protagonist Therapeutics
Last Price:
28.90
Seasonality Move:
24.27%
7 Day Trial
ALL ACCESS PASS
$
7
S&P Global: Private Equity Invests $36 Billion Into What?
Read MoreProtagonist Therapeutics Stock Forecast
- Over the next 52 weeks, Protagonist Therapeutics has on average historically risen by 45.3% based on the past 7 years of stock performance.
- Protagonist Therapeutics has risen higher in 3 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%
-
Is Protagonist Therapeutics Stock Undervalued?
The current Protagonist Therapeutics [PTGX] share price is $28.48. The Score for PTGX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal. - PTGX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Protagonist Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Protagonist Therapeutics has on average historically risen by 45.3% based on the past 7 years of stock performance.
Protagonist Therapeutics Stock Rating
Sell
48
Protagonist Therapeutics (PTGX)
is a Sell
Is Protagonist Therapeutics overpriced?
- Protagonist Therapeutics has risen higher in 3 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%
Protagonist Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Healthcare
Type:
stock
Website:
protagonist-inc.com
52-Week Data
52-Week High:
33.34
52-Week Low:
13.72
Prediction Charts
Market Cap:
1.66B
Price in USD:
28.48
Volume:
359.3K
Beta:
2.08
Technical Analysis
SMA50:
27.81
SMA100:
23.83
SMA200:
21.75
52-Wk Change:
30.88%
Stock Predictions
-
Is Protagonist Therapeutics stock public?
Yes, Protagonist Therapeutics is a publicly traded company. -
What is the Protagonist Therapeutics stock quote today?
The Protagonist Therapeutics stock price is 28.48 USD today. -
How to buy Protagonist Therapeutics stock online?
You can buy Protagonist Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Mar-8 | 31.41 | 30.32 | 31.56 | 30.20 |
Mar-11 | 30.32 | 30.12 | 30.76 | 29.78 |
Mar-12 | 30.04 | 29.90 | 30.57 | 29.49 |
Mar-13 | 29.90 | 30.20 | 30.63 | 29.43 |
Mar-14 | 29.88 | 28.33 | 29.94 | 28.14 |
Mar-15 | 28.23 | 28.98 | 29.97 | 28.23 |
Mar-18 | 28.81 | 28.45 | 29.22 | 28.25 |
Mar-19 | 28.56 | 28.82 | 28.95 | 28.26 |
Mar-20 | 28.65 | 28.88 | 28.94 | 28.02 |
Mar-21 | 29.40 | 28.35 | 29.73 | 28.25 |
Mar-22 | 28.37 | 28.03 | 28.42 | 27.83 |
Mar-25 | 28.11 | 27.89 | 28.44 | 27.63 |
Mar-26 | 28.42 | 28.00 | 28.42 | 27.59 |
Mar-27 | 28.17 | 28.48 | 28.62 | 27.94 |
Protagonist Therapeutics Earnings
Protagonist Therapeutics Earnings Report: Per Share Protagonist Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Protagonist Therapeutics Forecast Revenue Growth
Protagonist Therapeutics Stock Analysis: Historical quarterly revenues per share for Protagonist Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.87 per share, and a decrease next year of $0.23 per share.
* Protagonist Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.